The power of placebos is well-known. But placebos are now being tested as an actual treatment for a very real disorder—the crushing fatigue that often follows cancer treatment, even years later. And the participants will know they're taking placebos.
Dr. Patrick Soon-Shiong, founder and CEO of Culver City, Calif.-based NantHealth, which seeks to use big data to deliver personalized medicine, explains how NantHealth will work with researchers, clinicians and payers to transform healthcare.
As healthcare executives continue to face new challenges and encounter new opportunities, the next generation of leadership must evolve along with the changing industry, requiring new ideas and approaches in all sectors. Today's young executives are already proving they are up to the task.
MRIs, CT scans and X-rays for low back pain patients dropped by half last year at the UPMC health system in Pittsburgh after doctors started seeing reminders in the electronic health record that such tests can be unnecessary, a move inspired in part by the Choosing Wisely campaign.
The U.S. Supreme Court last week acted to keep Texas' 19 abortion clinics open, amid a legal fight that threatens to close more than half of them.
Lawmakers in Massachusetts are debating bills that seek to reduce boarding of behavioral health patients in hospital emergency departments and to keep them from being housed in correctional facilities.
A growing pipeline of senior housing construction projects has buoyed growth for the healthcare real estate investment trusts on Modern Healthcare's annual list of the largest healthcare REITs, experts say.
Aetna has signed a nearly $35 billion deal to buy rival Humana, which would dramatically expand its Medicare Advantage business.
Medicaid managed-care provider Centene Corp. is buying insurer Health Net in a $6.8 billion cash and stock deal.
Genentech, the maker of Avastin and other pricey cancer drugs, paid physicians and teaching hospitals more than any other drug or device company did in 2014, according to data published last week on the CMS' Open Payments website.
A bill to cap patients' out-of-pocket costs for prescription drugs that passed the California State Assembly will be considered by the state Senate this month, as policymakers across the country wrestle with the growing problem of unaffordable drugs.
In an effort to improve outcomes at the nation's 6,000 dialysis facilities, Medicare plans to cut reimbursement rates up to 2% if the facilities perform poorly on an expanded set of quality metrics.